
Nuclear Imaging Equipment Market - forecast to 2033 : By TECHNOLOGY (SPECT, PET, Planar Scintigraphy, Hybrid Imaging), APPLICATION (Oncology, Cardiology, Neurology, Orthopedics, Urology, Gastroenterology, Others), END-USER (Hospitals, Imaging Centers, Aca
Description
Nuclear Imaging Equipment Market - forecast to 2033 : By TECHNOLOGY (SPECT, PET, Planar Scintigraphy, Hybrid Imaging), APPLICATION (Oncology, Cardiology, Neurology, Orthopedics, Urology, Gastroenterology, Others), END-USER (Hospitals, Imaging Centers, Academic and Research Institutes, Pharmaceutical Companies, Others), RADIOPHARMACEUTICS (Technetium-99m, Fluorodeoxyglucose, Rubidium-82, Others), DETECTOR TYPE (Scintillation Detectors, Solid-State Detectors), MODALITY (Fixed Systems, Portable Systems), COMPONENT (Hardware, Software, Services), and Region
The Nuclear Imaging Equipment Market encompasses a range of advanced medical devices used for diagnostic and therapeutic procedures. These devices employ radioactive substances, known as radiotracers, to visualize and assess the function of various body systems, including the heart, brain, and other organs.
The Nuclear Imaging Equipment Market, market size was USD 2.7 Billion in 2023, and it is anticipated to grow to over 4.83 Billion by 2033, at a CAGR of over 5.4% during the forecast period.
The nuclear imaging equipment market is propelled by the rising prevalence of chronic diseases and advancements in technology that emphasize early and accurate disease detection. Innovations in Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) scanners, among others, are pivotal in providing detailed molecular-level images of the body's internal structures. This technological sophistication supports the diagnosis and monitoring of various conditions, including cancer, cardiovascular diseases, and neurological disorders. Furthermore, the stringent regulatory environment ensures that only high-quality, safe equipment is used, reinforcing the market's growth driven by increasing demand for early disease detection and precise diagnostics.
Key Trends:
- Technological Advancements: Rapid progress in technology is leading to the development of more efficient and accurate nuclear imaging equipment.
- Increased Demand in Oncology: The rising prevalence of cancer globally is driving the demand for nuclear imaging in oncology for accurate diagnosis and treatment.
- Adoption of AI and Machine Learning: The integration of AI and machine learning in nuclear imaging is improving the precision and speed of diagnosis.
- Growth in Geriatric Population: The increasing aging population worldwide is contributing to the growth of the nuclear imaging equipment market due to the higher incidence of chronic diseases in this demographic.
- Regulatory Support and Funding: Governments and regulatory bodies are providing support and funding for the development and adoption of nuclear imaging technologies..
- Technological Advancements: Continuous innovation and development of high-performance imaging equipment.
- Aging Population: The increasing number of elderly people worldwide, leading to a higher demand for diagnostic procedures.
- Prevalence of Chronic Diseases: Rising incidence of cancer and cardiovascular diseases requiring nuclear imaging for diagnosis and treatment.
- Increase in Healthcare Expenditure: Growing investment in healthcare infrastructure and services, especially in developing countries.
- Government Initiatives: Supportive government policies and funding for research and development in nuclear imaging technologies.
- High Cost of Equipment: The high initial cost of nuclear imaging equipment can be a significant barrier for many healthcare providers, particularly in developing countries.
- Regulatory Hurdles: Strict regulations and lengthy approval processes can delay the introduction of new equipment into the market.
- Shortage of Radiopharmaceuticals: The production and supply of radiopharmaceuticals, which are crucial for nuclear imaging, can be inconsistent, affecting the market growth.
- Lack of Trained Professionals: The complexity of nuclear imaging equipment requires highly trained professionals for operation and interpretation, which are often in short supply.
- Radiation Exposure Concerns: Despite the benefits of nuclear imaging, concerns about radiation exposure can deter patients and healthcare providers from using this technology...
TECHNOLOGY (SPECT, PET, Planar Scintigraphy, Hybrid Imaging), APPLICATION (Oncology, Cardiology, Neurology, Orthopedics, Urology, Gastroenterology, Others), END-USER (Hospitals, Imaging Centers, Academic and Research Institutes, Pharmaceutical Companies, Others), RADIOPHARMACEUTICS (Technetium-99m, Fluorodeoxyglucose, Rubidium-82, Others), DETECTOR TYPE (Scintillation Detectors, Solid-State Detectors), MODALITY (Fixed Systems, Portable Systems), COMPONENT (Hardware, Software, Services), and Region
Key Players:
The Nuclear Imaging Equipment Market includes players such as GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, Hitachi Medical, Neusoft Medical Systems, Mediso Medical Imaging Systems, DDD-Diagnostics, SurgicEye, CMR Naviscan Kromek Group, Gamma Medica, Capintec, Toshiba, Biosensors International, Blue Earth Diagnostics, Cardinal Health, Digirad Corporation, Eczacibasi-Monrol, and Fujifilm Holdings, among others.
Value Chain Analysis:
The value chain analysis for the Nuclear Imaging Equipment Market can be delineated into five pivotal stages: Raw Material Procurement, R&D, Product Approval, Large Scale Manufacturing, and Sales and Marketing. Each stage plays a crucial role in ensuring the seamless progression from concept to market-ready product, while also ensuring compliance, quality, and market competitiveness. Below is a detailed analysis of each stage:
- Raw Material Procurement: Identify sources of raw materials, assess their availability, quality, and sustainability. Understanding market dynamics, pricing trends, and potential risks associated with sourcing materials is crucial. This involves establishing robust relationships with suppliers, ensuring ethical sourcing practices, and maintaining a steady supply chain to avoid disruptions. Additionally, the procurement process must consider the specific requirements for high-purity materials and components necessary for nuclear imaging equipment.
- R&D (Research and Development): R&D focuses on market analysis, trend forecasting, feasibility studies, and conducting experiments to develop new products or enhance existing ones. In the context of nuclear imaging equipment, this includes innovating cutting-edge imaging technologies, improving resolution and accuracy, and integrating advanced software for image processing. Collaboration with academic institutions, leveraging grants and funding, and protecting intellectual property through patents are also critical components of this stage.
- Product Approval: Understanding legal requirements, industry regulations, and certification processes is paramount. This stage involves rigorous testing of products for safety, efficacy, and environmental impact. Compliance with international standards such as FDA (Food and Drug Administration) approval in the US, CE marking in Europe, and other regional regulatory bodies is essential. Additionally, conducting clinical trials, gathering empirical data, and ensuring adherence to radiation safety standards are key activities.
- Large Scale Manufacturing: Optimizing production processes, improving efficiency, and reducing costs are the primary objectives. This includes process engineering, automation technologies, and supply chain management to enhance productivity and quality. For nuclear imaging equipment, maintaining precision and consistency in manufacturing is critical. Quality control measures, lean manufacturing principles, and continuous improvement practices help in minimizing defects and ensuring high-quality output. Strategic partnerships with component manufacturers and investing in state-of-the-art manufacturing facilities are also vital.
- Sales and Marketing: Understanding customer needs, market trends, and competitive landscape is essential for effective sales and marketing. This involves market segmentation, consumer behavior analysis, and branding strategies to position the product effectively. Developing strong relationships with healthcare providers, hospitals, and diagnostic centers, as well as participating in industry conferences and trade shows, can enhance market penetration. Digital marketing, content creation, and leveraging social media platforms to educate potential customers and highlight product benefits are also crucial strategies. Furthermore, providing excellent after-sales support and training for end-users ensures customer satisfaction and loyalty..
- Estimates and forecast the overall market size for the total market, across type, application, and region
- Detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling
- Identify factors influencing market growth and challenges, opportunities, drivers, and restraints
- Identify factors that could limit company participation in identified international markets to help properly calibrate market share expectations and growth rates
- Trace and evaluate key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities
- Thoroughly analyze smaller market segments strategically, focusing on their potential, individual patterns of growth, and impact on the overall market
- To thoroughly outline the competitive landscape within the market, including an assessment of business and corporate strategies, aimed at monitoring and dissecting competitive advancements
- Identify the primary market participants, based on their business objectives, regional footprint, product offerings, and strategic initiatives.
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
Table of Contents
350 Pages
- 1.0: MARKET DEFINITION
- 1.1: MARKET SEGMENTATION
- 1.2: REGIONAL COVERAGE
- 1.3: KEY COMPANY PROFILES
- 1.4: DATA SNAPSHOT
- 2.0: SUMMARY
- 2.1: KEY OPINION LEADERS
- 2.2: KEY HIGHLIGHTS BY TECHNOLOGY
- 2.3: KEY HIGHLIGHTS BY APPLICATION
- 2.4: KEY HIGHLIGHTS BY END-USER
- 2.5: KEY HIGHLIGHTS BY RADIOPHARMACEUTICS
- 2.6: KEY HIGHLIGHTS BY DETECTOR TYPE
- 2.7: KEY HIGHLIGHTS BY MODALITY
- 2.8: KEY HIGHLIGHTS BY COMPONENT
- 2.9: KEY HIGHLIGHTS BY REGION
- 2.10: KEY HIGHLIGHTS BY NORTH AMERICA
- 2.11: KEY HIGHLIGHTS BY LATIN AMERICA
- 2.12: KEY HIGHLIGHTS BY EUROPE
- 2.13: KEY HIGHLIGHTS BY ASIA/PACIFIC
- 2.14: KEY HIGHLIGHTS BY MIDDLE EAST/AFRICA
- 3.0: MARKET ATTRACTIVENESS ANALYSIS BY TECHNOLOGY
- 3.1: MARKET ATTRACTIVENESS ANALYSIS BY APPLICATION
- 3.2: MARKET ATTRACTIVENESS ANALYSIS BY END-USER
- 3.3: MARKET ATTRACTIVENESS ANALYSIS BY RADIOPHARMACEUTICS
- 3.4: MARKET ATTRACTIVENESS ANALYSIS BY DETECTOR TYPE
- 3.5: MARKET ATTRACTIVENESS ANALYSIS BY MODALITY
- 3.6: MARKET ATTRACTIVENESS ANALYSIS BY COMPONENT
- 3.7: MARKET ATTRACTIVENESS ANALYSIS BY REGION
- 3.8: MARKET ATTRACTIVENESS ANALYSIS BY COUNTRY
- 4.0: MARKET TRENDS
- 4.1: MARKET DRIVERS
- 4.2: MARKET OPPORTUNITIES
- 4.3: MARKET RESTRAINTS
- 4.4: MARKET THREATS
- 4.5: IMPACT ANALYSIS
- 5.0: PORTERS FIVE FORCES
- 5.1: ANSOFF MATRIX
- 5.2: PESTLE ANALYSIS
- 5.3: VALUE CHAIN ANALYSIS
- 6.0: IMPACT OF COVID-19 ON MARKET
- 7.0: IMPACT OF RUSSIA-UKRAINE WAR
- 8.0: PARENT MARKET ANALYSIS
- 8.1: REGULATORY LANDSCAPE
- 8.2: PRICING ANALYSIS
- 8.3: DEMAND SUPPLY ANALYSIS
- 8.4: DEMAND SUPPLY ANALYSIS
- 8.5: CONSUMER BUYING INTEREST
- 8.6: CONSUMER BUYING INTEREST
- 8.7: SUPPLY CHAIN ANALYSIS
- 8.8: COMPETITION PRODUCT ANALYSIS BY MANUFACTURER
- 8.9: TECHNOLOGICAL ADVANCEMENTS
- 8.10: RECENT DEVELOPMENTS
- 8.11: CASE STUDIES
- 9.0: MARKET SIZE AND FORECAST – BY VALUE
- 9.1: MARKET SIZE AND FORECAST – BY VOLUME
- 10.0: TECHNOLOGY OVERVIEW
- 10.1: MARKET SIZE AND FORECAST – BY TECHNOLOGY
- 10.2: SPECT OVERVIEW
- 10.3: SPECT BY REGION
- 10.4: SPECT BY COUNTRY
- 10.5: PET OVERVIEW
- 10.6: PET BY REGION
- 10.7: PET BY COUNTRY
- 10.8: PLANAR SCINTIGRAPHY OVERVIEW
- 10.9: PLANAR SCINTIGRAPHY BY REGION
- 10.10: PLANAR SCINTIGRAPHY BY COUNTRY
- 10.11: HYBRID IMAGING OVERVIEW
- 10.12: HYBRID IMAGING BY REGION
- 10.13: HYBRID IMAGING BY COUNTRY
- 11.0: APPLICATION OVERVIEW
- 11.1: MARKET SIZE AND FORECAST – BY APPLICATION
- 11.2: ONCOLOGY OVERVIEW
- 11.3: ONCOLOGY BY REGION
- 11.4: ONCOLOGY BY COUNTRY
- 11.5: CARDIOLOGY OVERVIEW
- 11.6: CARDIOLOGY BY REGION
- 11.7: CARDIOLOGY BY COUNTRY
- 11.8: NEUROLOGY OVERVIEW
- 11.9: NEUROLOGY BY REGION
- 11.10: NEUROLOGY BY COUNTRY
- 11.11: ORTHOPEDICS OVERVIEW
- 11.12: ORTHOPEDICS BY REGION
- 11.13: ORTHOPEDICS BY COUNTRY
- 11.14: UROLOGY OVERVIEW
- 11.15: UROLOGY BY REGION
- 11.16: UROLOGY BY COUNTRY
- 11.17: GASTROENTEROLOGY OVERVIEW
- 11.18: GASTROENTEROLOGY BY REGION
- 11.19: GASTROENTEROLOGY BY COUNTRY
- 11.20: OTHERS OVERVIEW
- 11.21: OTHERS BY REGION
- 11.22: OTHERS BY COUNTRY
- 12.0: END-USER OVERVIEW
- 12.1: MARKET SIZE AND FORECAST – BY END-USER
- 12.2: HOSPITALS OVERVIEW
- 12.3: HOSPITALS BY REGION
- 12.4: HOSPITALS BY COUNTRY
- 12.5: IMAGING CENTERS OVERVIEW
- 12.6: IMAGING CENTERS BY REGION
- 12.7: IMAGING CENTERS BY COUNTRY
- 12.8: ACADEMIC AND RESEARCH INSTITUTES OVERVIEW
- 12.9: ACADEMIC AND RESEARCH INSTITUTES BY REGION
- 12.10: ACADEMIC AND RESEARCH INSTITUTES BY COUNTRY
- 12.11: PHARMACEUTICAL COMPANIES OVERVIEW
- 12.12: PHARMACEUTICAL COMPANIES BY REGION
- 12.13: PHARMACEUTICAL COMPANIES BY COUNTRY
- 12.14: OTHERS OVERVIEW
- 12.15: OTHERS BY REGION
- 12.16: OTHERS BY COUNTRY
- 13.0: RADIOPHARMACEUTICS OVERVIEW
- 13.1: MARKET SIZE AND FORECAST – BY RADIOPHARMACEUTICS
- 13.2: TECHNETIUM-99M OVERVIEW
- 13.3: TECHNETIUM-99M BY REGION
- 13.4: TECHNETIUM-99M BY COUNTRY
- 13.5: FLUORODEOXYGLUCOSE OVERVIEW
- 13.6: FLUORODEOXYGLUCOSE BY REGION
- 13.7: FLUORODEOXYGLUCOSE BY COUNTRY
- 13.8: RUBIDIUM-82 OVERVIEW
- 13.9: RUBIDIUM-82 BY REGION
- 13.10: RUBIDIUM-82 BY COUNTRY
- 13.11: OTHERS OVERVIEW
- 13.12: OTHERS BY REGION
- 13.13: OTHERS BY COUNTRY
- 14.0: DETECTOR TYPE OVERVIEW
- 14.1: MARKET SIZE AND FORECAST – BY DETECTOR TYPE
- 14.2: SCINTILLATION DETECTORS OVERVIEW
- 14.3: SCINTILLATION DETECTORS BY REGION
- 14.4: SCINTILLATION DETECTORS BY COUNTRY
- 14.5: SOLID-STATE DETECTORS OVERVIEW
- 14.6: SOLID-STATE DETECTORS BY REGION
- 14.7: SOLID-STATE DETECTORS BY COUNTRY
- 15.0: MODALITY OVERVIEW
- 15.1: MARKET SIZE AND FORECAST – BY MODALITY
- 15.2: FIXED SYSTEMS OVERVIEW
- 15.3: FIXED SYSTEMS BY REGION
- 15.4: FIXED SYSTEMS BY COUNTRY
- 15.5: PORTABLE SYSTEMS OVERVIEW
- 15.6: PORTABLE SYSTEMS BY REGION
- 15.7: PORTABLE SYSTEMS BY COUNTRY
- 16.0: COMPONENT OVERVIEW
- 16.1: MARKET SIZE AND FORECAST – BY COMPONENT
- 16.2: HARDWARE OVERVIEW
- 16.3: HARDWARE BY REGION
- 16.4: HARDWARE BY COUNTRY
- 16.5: SOFTWARE OVERVIEW
- 16.6: SOFTWARE BY REGION
- 16.7: SOFTWARE BY COUNTRY
- 16.8: SERVICES OVERVIEW
- 16.9: SERVICES BY REGION
- 16.10: SERVICES BY COUNTRY
- 17.0: REGION OVERVIEW
- 17.1: MARKET SIZE AND FORECAST - BY REGION
- 17.2: NORTH AMERICA OVERVIEW
- 17.3: NORTH AMERICA BY COUNTRY
- 17.4: UNITED STATES OVERVIEW
- 17.5: UNITED STATES OVERVIEW
- 17.6: UNITED STATES OVERVIEW
- 17.7: UNITED STATES OVERVIEW
- 17.8: UNITED STATES OVERVIEW
- 17.9: UNITED STATES OVERVIEW
- 17.10: UNITED STATES OVERVIEW
- 17.11: UNITED STATES OVERVIEW
- 17.12: LOCAL MARKET ANALYSIS - UNITED STATES
- 17.13: CANADA OVERVIEW
- 17.14: CANADA OVERVIEW
- 17.15: CANADA OVERVIEW
- 17.16: CANADA OVERVIEW
- 17.17: CANADA OVERVIEW
- 17.18: CANADA OVERVIEW
- 17.19: CANADA OVERVIEW
- 17.20: CANADA OVERVIEW
- 17.21: LOCAL MARKET ANALYSIS - CANADA
- 17.22: LATIN AMERICA OVERVIEW
- 17.23: LATIN AMERICA BY COUNTRY
- 17.24: MEXICO OVERVIEW
- 17.25: MEXICO OVERVIEW
- 17.26: MEXICO OVERVIEW
- 17.27: MEXICO OVERVIEW
- 17.28: MEXICO OVERVIEW
- 17.29: MEXICO OVERVIEW
- 17.30: MEXICO OVERVIEW
- 17.31: MEXICO OVERVIEW
- 17.32: LOCAL MARKET ANALYSIS - MEXICO
- 17.33: BRAZIL OVERVIEW
- 17.34: BRAZIL OVERVIEW
- 17.35: BRAZIL OVERVIEW
- 17.36: BRAZIL OVERVIEW
- 17.37: BRAZIL OVERVIEW
- 17.38: BRAZIL OVERVIEW
- 17.39: BRAZIL OVERVIEW
- 17.40: BRAZIL OVERVIEW
- 17.41: LOCAL MARKET ANALYSIS - BRAZIL
- 17.42: ARGENTINA OVERVIEW
- 17.43: ARGENTINA OVERVIEW
- 17.44: ARGENTINA OVERVIEW
- 17.45: ARGENTINA OVERVIEW
- 17.46: ARGENTINA OVERVIEW
- 17.47: ARGENTINA OVERVIEW
- 17.48: ARGENTINA OVERVIEW
- 17.49: ARGENTINA OVERVIEW
- 17.50: LOCAL MARKET ANALYSIS - ARGENTINA
- 17.51: REST OF LATAM OVERVIEW
- 17.52: REST OF LATAM OVERVIEW
- 17.53: REST OF LATAM OVERVIEW
- 17.54: REST OF LATAM OVERVIEW
- 17.55: REST OF LATAM OVERVIEW
- 17.56: REST OF LATAM OVERVIEW
- 17.57: REST OF LATAM OVERVIEW
- 17.58: REST OF LATAM OVERVIEW
- 17.59: LOCAL MARKET ANALYSIS - REST OF LATAM
- 17.60: EUROPE OVERVIEW
- 17.61: EUROPE BY COUNTRY
- 17.62: GERMANY OVERVIEW
- 17.63: GERMANY OVERVIEW
- 17.64: GERMANY OVERVIEW
- 17.65: GERMANY OVERVIEW
- 17.66: GERMANY OVERVIEW
- 17.67: GERMANY OVERVIEW
- 17.68: GERMANY OVERVIEW
- 17.69: GERMANY OVERVIEW
- 17.70: LOCAL MARKET ANALYSIS - GERMANY
- 17.71: FRANCE OVERVIEW
- 17.72: FRANCE OVERVIEW
- 17.73: FRANCE OVERVIEW
- 17.74: FRANCE OVERVIEW
- 17.75: FRANCE OVERVIEW
- 17.76: FRANCE OVERVIEW
- 17.77: FRANCE OVERVIEW
- 17.78: FRANCE OVERVIEW
- 17.79: LOCAL MARKET ANALYSIS - FRANCE
- 17.80: UNITED KINGDOM OVERVIEW
- 17.81: UNITED KINGDOM OVERVIEW
- 17.82: UNITED KINGDOM OVERVIEW
- 17.83: UNITED KINGDOM OVERVIEW
- 17.84: UNITED KINGDOM OVERVIEW
- 17.85: UNITED KINGDOM OVERVIEW
- 17.86: UNITED KINGDOM OVERVIEW
- 17.87: UNITED KINGDOM OVERVIEW
- 17.88: LOCAL MARKET ANALYSIS - UNITED KINGDOM
- 17.89: RUSSIA OVERVIEW
- 17.90: RUSSIA OVERVIEW
- 17.91: RUSSIA OVERVIEW
- 17.92: RUSSIA OVERVIEW
- 17.93: RUSSIA OVERVIEW
- 17.94: RUSSIA OVERVIEW
- 17.95: RUSSIA OVERVIEW
- 17.96: RUSSIA OVERVIEW
- 17.97: LOCAL MARKET ANALYSIS - RUSSIA
- 17.98: SPAIN OVERVIEW
- 17.99: SPAIN OVERVIEW
- 17.100: SPAIN OVERVIEW
- 17.101: SPAIN OVERVIEW
- 17.102: SPAIN OVERVIEW
- 17.103: SPAIN OVERVIEW
- 17.104: SPAIN OVERVIEW
- 17.105: SPAIN OVERVIEW
- 17.106: LOCAL MARKET ANALYSIS - SPAIN
- 17.107: ITALY OVERVIEW
- 17.108: ITALY OVERVIEW
- 17.109: ITALY OVERVIEW
- 17.110: ITALY OVERVIEW
- 17.111: ITALY OVERVIEW
- 17.112: ITALY OVERVIEW
- 17.113: ITALY OVERVIEW
- 17.114: ITALY OVERVIEW
- 17.115: LOCAL MARKET ANALYSIS - ITALY
- 17.116: NETHERLANDS OVERVIEW
- 17.117: NETHERLANDS OVERVIEW
- 17.118: NETHERLANDS OVERVIEW
- 17.119: NETHERLANDS OVERVIEW
- 17.120: NETHERLANDS OVERVIEW
- 17.121: NETHERLANDS OVERVIEW
- 17.122: NETHERLANDS OVERVIEW
- 17.123: NETHERLANDS OVERVIEW
- 17.124: LOCAL MARKET ANALYSIS - NETHERLANDS
- 17.125: ISRAEL OVERVIEW
- 17.126: ISRAEL OVERVIEW
- 17.127: ISRAEL OVERVIEW
- 17.128: ISRAEL OVERVIEW
- 17.129: ISRAEL OVERVIEW
- 17.130: ISRAEL OVERVIEW
- 17.131: ISRAEL OVERVIEW
- 17.132: ISRAEL OVERVIEW
- 17.133: LOCAL MARKET ANALYSIS - ISRAEL
- 17.134: TURKEY OVERVIEW
- 17.135: TURKEY OVERVIEW
- 17.136: TURKEY OVERVIEW
- 17.137: TURKEY OVERVIEW
- 17.138: TURKEY OVERVIEW
- 17.139: TURKEY OVERVIEW
- 17.140: TURKEY OVERVIEW
- 17.141: TURKEY OVERVIEW
- 17.142: LOCAL MARKET ANALYSIS - TURKEY
- 17.143: REST OF EUROPE OVERVIEW
- 17.144: REST OF EUROPE OVERVIEW
- 17.145: REST OF EUROPE OVERVIEW
- 17.146: REST OF EUROPE OVERVIEW
- 17.147: REST OF EUROPE OVERVIEW
- 17.148: REST OF EUROPE OVERVIEW
- 17.149: REST OF EUROPE OVERVIEW
- 17.150: REST OF EUROPE OVERVIEW
- 17.151: LOCAL MARKET ANALYSIS - REST OF EUROPE
- 17.152: ASIA/PACIFIC OVERVIEW
- 17.153: ASIA/PACIFIC BY COUNTRY
- 17.154: CHINA OVERVIEW
- 17.155: CHINA OVERVIEW
- 17.156: CHINA OVERVIEW
- 17.157: CHINA OVERVIEW
- 17.158: CHINA OVERVIEW
- 17.159: CHINA OVERVIEW
- 17.160: CHINA OVERVIEW
- 17.161: CHINA OVERVIEW
- 17.162: LOCAL MARKET ANALYSIS - CHINA
- 17.163: INDIA OVERVIEW
- 17.164: INDIA OVERVIEW
- 17.165: INDIA OVERVIEW
- 17.166: INDIA OVERVIEW
- 17.167: INDIA OVERVIEW
- 17.168: INDIA OVERVIEW
- 17.169: INDIA OVERVIEW
- 17.170: INDIA OVERVIEW
- 17.171: LOCAL MARKET ANALYSIS - INDIA
- 17.172: JAPAN OVERVIEW
- 17.173: JAPAN OVERVIEW
- 17.174: JAPAN OVERVIEW
- 17.175: JAPAN OVERVIEW
- 17.176: JAPAN OVERVIEW
- 17.177: JAPAN OVERVIEW
- 17.178: JAPAN OVERVIEW
- 17.179: JAPAN OVERVIEW
- 17.180: LOCAL MARKET ANALYSIS - JAPAN
- 17.181: AUSTRALIA OVERVIEW
- 17.182: AUSTRALIA OVERVIEW
- 17.183: AUSTRALIA OVERVIEW
- 17.184: AUSTRALIA OVERVIEW
- 17.185: AUSTRALIA OVERVIEW
- 17.186: AUSTRALIA OVERVIEW
- 17.187: AUSTRALIA OVERVIEW
- 17.188: AUSTRALIA OVERVIEW
- 17.189: LOCAL MARKET ANALYSIS - AUSTRALIA
- 17.190: INDONESIA OVERVIEW
- 17.191: INDONESIA OVERVIEW
- 17.192: INDONESIA OVERVIEW
- 17.193: INDONESIA OVERVIEW
- 17.194: INDONESIA OVERVIEW
- 17.195: INDONESIA OVERVIEW
- 17.196: INDONESIA OVERVIEW
- 17.197: INDONESIA OVERVIEW
- 17.198: LOCAL MARKET ANALYSIS - INDONESIA
- 17.199: MALAYSIA OVERVIEW
- 17.200: MALAYSIA OVERVIEW
- 17.201: MALAYSIA OVERVIEW
- 17.202: MALAYSIA OVERVIEW
- 17.203: MALAYSIA OVERVIEW
- 17.204: MALAYSIA OVERVIEW
- 17.205: MALAYSIA OVERVIEW
- 17.206: MALAYSIA OVERVIEW
- 17.207: LOCAL MARKET ANALYSIS - MALAYSIA
- 17.208: REST OF APAC OVERVIEW
- 17.209: REST OF APAC OVERVIEW
- 17.210: REST OF APAC OVERVIEW
- 17.211: REST OF APAC OVERVIEW
- 17.212: REST OF APAC OVERVIEW
- 17.213: REST OF APAC OVERVIEW
- 17.214: REST OF APAC OVERVIEW
- 17.215: REST OF APAC OVERVIEW
- 17.216: LOCAL MARKET ANALYSIS - REST OF APAC
- 17.217: MIDDLE EAST/AFRICA OVERVIEW
- 17.218: MIDDLE EAST/AFRICA BY COUNTRY
- 17.219: SAUDI ARABIA OVERVIEW
- 17.220: SAUDI ARABIA OVERVIEW
- 17.221: SAUDI ARABIA OVERVIEW
- 17.222: SAUDI ARABIA OVERVIEW
- 17.223: SAUDI ARABIA OVERVIEW
- 17.224: SAUDI ARABIA OVERVIEW
- 17.225: SAUDI ARABIA OVERVIEW
- 17.226: SAUDI ARABIA OVERVIEW
- 17.227: LOCAL MARKET ANALYSIS - SAUDI ARABIA
- 17.228: UAE OVERVIEW
- 17.229: UAE OVERVIEW
- 17.230: UAE OVERVIEW
- 17.231: UAE OVERVIEW
- 17.232: UAE OVERVIEW
- 17.233: UAE OVERVIEW
- 17.234: UAE OVERVIEW
- 17.235: UAE OVERVIEW
- 17.236: LOCAL MARKET ANALYSIS - UAE
- 17.237: SOUTH AFRICA OVERVIEW
- 17.238: SOUTH AFRICA OVERVIEW
- 17.239: SOUTH AFRICA OVERVIEW
- 17.240: SOUTH AFRICA OVERVIEW
- 17.241: SOUTH AFRICA OVERVIEW
- 17.242: SOUTH AFRICA OVERVIEW
- 17.243: SOUTH AFRICA OVERVIEW
- 17.244: SOUTH AFRICA OVERVIEW
- 17.245: LOCAL MARKET ANALYSIS - SOUTH AFRICA
- 17.246: IRAN OVERVIEW
- 17.247: IRAN OVERVIEW
- 17.248: IRAN OVERVIEW
- 17.249: IRAN OVERVIEW
- 17.250: IRAN OVERVIEW
- 17.251: IRAN OVERVIEW
- 17.252: IRAN OVERVIEW
- 17.253: IRAN OVERVIEW
- 17.254: LOCAL MARKET ANALYSIS - IRAN
- 17.255: QATAR OVERVIEW
- 17.256: QATAR OVERVIEW
- 17.257: QATAR OVERVIEW
- 17.258: QATAR OVERVIEW
- 17.259: QATAR OVERVIEW
- 17.260: QATAR OVERVIEW
- 17.261: QATAR OVERVIEW
- 17.262: QATAR OVERVIEW
- 17.263: LOCAL MARKET ANALYSIS - QATAR
- 17.264: REST OF MEA OVERVIEW
- 17.265: REST OF MEA OVERVIEW
- 17.266: REST OF MEA OVERVIEW
- 17.267: REST OF MEA OVERVIEW
- 17.268: REST OF MEA OVERVIEW
- 17.269: REST OF MEA OVERVIEW
- 17.270: REST OF MEA OVERVIEW
- 17.271: REST OF MEA OVERVIEW
- 17.272: LOCAL MARKET ANALYSIS - REST OF MEA
- 18.0: COMPETITION OVERVIEW
- 18.1: MARKET SHARE ANALYSIS
- 18.2: MARKET REVENUE BY KEY COMPANIES
- 18.3: MARKET POSITIONING
- 18.4: VENDORS BENCHMARKING
- 18.5: STRATEGY BENCHMARKING
- 18.6: STRATEGY BENCHMARKING
- 19.0: GE Healthcare
- 19.1: GE Healthcare
- 19.2: GE Healthcare
- 19.3: GE Healthcare
- 19.4: GE Healthcare
- 19.5: Siemens Healthineers
- 19.6: Siemens Healthineers
- 19.7: Siemens Healthineers
- 19.8: Siemens Healthineers
- 19.9: Siemens Healthineers
- 19.10: Philips Healthcare
- 19.11: Philips Healthcare
- 19.12: Philips Healthcare
- 19.13: Philips Healthcare
- 19.14: Philips Healthcare
- 19.15: Canon Medical Systems
- 19.16: Canon Medical Systems
- 19.17: Canon Medical Systems
- 19.18: Canon Medical Systems
- 19.19: Canon Medical Systems
- 19.20: Hitachi Medical
- 19.21: Hitachi Medical
- 19.22: Hitachi Medical
- 19.23: Hitachi Medical
- 19.24: Hitachi Medical
- 19.25: Neusoft Medical Systems
- 19.26: Neusoft Medical Systems
- 19.27: Neusoft Medical Systems
- 19.28: Neusoft Medical Systems
- 19.29: Neusoft Medical Systems
- 19.30: Mediso Medical Imaging Systems
- 19.31: Mediso Medical Imaging Systems
- 19.32: Mediso Medical Imaging Systems
- 19.33: Mediso Medical Imaging Systems
- 19.34: Mediso Medical Imaging Systems
- 19.35: DDD-Diagnostic
- 19.36: DDD-Diagnostic
- 19.37: DDD-Diagnostic
- 19.38: DDD-Diagnostic
- 19.39: DDD-Diagnostic
- 19.40: SurgicEye
- 19.41: SurgicEye
- 19.42: SurgicEye
- 19.43: SurgicEye
- 19.44: SurgicEye
- 19.45: CMR Naviscan
- 19.46: CMR Naviscan
- 19.47: CMR Naviscan
- 19.48: CMR Naviscan
- 19.49: CMR Naviscan
- 19.50: Kromek Group
- 19.51: Kromek Group
- 19.52: Kromek Group
- 19.53: Kromek Group
- 19.54: Kromek Group
- 19.55: Gamma Medica
- 19.56: Gamma Medica
- 19.57: Gamma Medica
- 19.58: Gamma Medica
- 19.59: Gamma Medica
- 19.60: Capintec
- 19.61: Capintec
- 19.62: Capintec
- 19.63: Capintec
- 19.64: Capintec
- 19.65: Biosensors International Group
- 19.66: Biosensors International Group
- 19.67: Biosensors International Group
- 19.68: Biosensors International Group
- 19.69: Biosensors International Group
- 19.70: Blue Earth Diagnostics
- 19.71: Blue Earth Diagnostics
- 19.72: Blue Earth Diagnostics
- 19.73: Blue Earth Diagnostics
- 19.74: Blue Earth Diagnostics
- 19.75: Cardinal Health
- 19.76: Cardinal Health
- 19.77: Cardinal Health
- 19.78: Cardinal Health
- 19.79: Cardinal Health
- 19.80: Digirad Corporation
- 19.81: Digirad Corporation
- 19.82: Digirad Corporation
- 19.83: Digirad Corporation
- 19.84: Digirad Corporation
- 19.85: Eczacibasi-Monrol Nuclear Products
- 19.86: Eczacibasi-Monrol Nuclear Products
- 19.87: Eczacibasi-Monrol Nuclear Products
- 19.88: Eczacibasi-Monrol Nuclear Products
- 19.89: Eczacibasi-Monrol Nuclear Products
- 19.90: Fujifilm Holdings Corporation
- 19.91: Fujifilm Holdings Corporation
- 19.92: Fujifilm Holdings Corporation
- 19.93: Fujifilm Holdings Corporation
- 19.94: Fujifilm Holdings Corporation
- 562})
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.